Medical Health & Life Science Research News

New report examines the cancer biomarker market to grow at 14.07% CAGR during 2017-2025

Cancer biomarker market is geographically segmented into North America, Asia-Pacific, Europe and the Rest of World.

- Agency -.

Global cancer biomarker market report is the latest addition to reportsnreports.com industry research reports collection. The report is about 145 pages and provides 63 List of Figure; the report is published in Aug -2017.

The global Cancer Biomarker Marketis expected to grow at a CAGR of 14.07% between the years 2017- 2025, generating a net worth of $33026 million by the end of 2025. Some of the important drivers for the global biomarker market include encouragement by the FDA for biomarker development, the adoption of western lifestyles in developing countries, heavy investments by government and private funds for cancer-related research,.

- Agency -.

At present, the genetic and genomic biomarkers are the leading revenue generating segment of the market.

Get Report @ www.reportsnreports.com/contacts/d…aspx?name=1160257 .

Competitive Insights

Some of the noted companies in the global market are Abbott Laboratories, Agendia N.V, Affymetrix, Inc.(Acquired By Thermofisher), Agilent Technologies, Inc, Becton Dickinson And Company, Astellas Pharma Inc, Clarient, Inc. (Acquired By Neogenomics Laboratories), Illumina, Inc, Diadexus Inc (Acquired By Diazyme Laboratories), Qiagen N.V, Roche Diagnostics Ltd, Aureon Biosciences, Inc, Biomoda Inc and Ambrilia Biopharma Inc.

Access Report Copy @ www.reportsnreports.com/purchase.aspx?name=1160257 .

The Global cancer biomarker market is segmented on the basis of the Discovery and Diagnostics and on the basis of the Diseases. The discovery and diagnostics segment is sub-divided into Biomarker discovery and Diagnostics.

The biomarkers discovery is further sub-segmented into imaging, genetic methods, protein methods, and metabolomics; whereas the Diagnostic market is sub-segmented into proteomics, genetic and genomic markers, DNA microarrays, immunohistochemical tests, immunoassays, pharmacogenomics, molecular diagnostic assays, monoclonal antibodies, flow cytometry, stem cell markers. The Diseases segment is further sub-segmented into various types of cancers such as breast cancer, lung cancer, colorectal cancer, cervical cancer, prostate cancer, etc

The global cancer biomarker market is geographically segmented into North America (U.S. & Canada), Asia-Pacific (India, China, Japan, Australia, South Korea, and Rest of APAC), Europe (United Kingdom, Germany, Italy, France, Spain, rest of Europe) and the Rest of World (Latin America, Middle East and North Africa and Rest of Africa).

The North American region is the most dominant region in the global market, with the United States acting as the major contributor. Moreover, the Asia-Pacific region is anticipated to be the fastest growing regional market owing to the increasing prevalence of cancer in the region.

Market Opportunities: Growing Trend of Distributed Power Generation and Shifting Towards Gas-Fired Power Plants

Market Challenges: Lacking Acceptance of the Cancer Biomarker and Unfavorable Compensation Situation, High Cost of Developing Companion Diagnostics, Rigorous Regulatory Agenda, Dearth of Skilful Workers

Market Drivers: Adoption of Western Lifestyles In Developing Regions, Growing Prevalence On Research of Cancer Biomarkers, Encouragement For Biomarker Development By Fda, Improved Precision and Speed of Diagnosis, High Investment Through Government and Private Funds In Cancer Related Research, Development of Highly Specific Drugs

Figure List
Figure # 1 Increasing Number of People Living With Cancer Across the Globe For Period 2012-2020 (Million)
Figure # 2 Most Common Cancer Causing Deaths In 2015
Figure # 3 Pharmacogenomic Biomarkers Information In Drug Labeling
Figure # 4 Percentage of Patients Ineffective For Particular Drug
Figure # 5 List of Cleared Or Approved Companion Diagnostic Devices (Imaging Tools and In Vitro) By Fda
Figure # 6 Global Genetic Methods Market 2017-2025 ($Million)
Figure # 7 Global Dna Arrays Market 2017-2025 ($Million)
Figure # 8 Global Polymerase Chain Reaction Market 2017-2025 ($Million)
Figure # 9 Global Reverse Transcriptase Polymerase Chain Reaction Market 2017-2025 ($Million)
Figure # 10 Global Fluorescent In Situ Hybridization Market 2017-2025 ($Million)
Figure # 11 Global Southern Blot Market 2017-2025 ($Million)
Figure # 12 Global Imaging Market 2017-2025 ($Million) and more…

News From

ReportsnReports - Industry Trends & ForecastsReportsnReports
Category: Market Research Publishers and RetailersCompany profile: ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets.